This March, Alosenta was pleased to visit Tokyo, with Commercial Development Executive Judy Kingswolf-Yamakawa in attendance for iCONM and BioLabs’ Investor Day.
It was a valuable opportunity to connect with APAC investors, researchers, and pharmaceutical innovators, and to better understand the evolving landscape of biotech collaboration in Japan and the broader region.
The panel discussions offered particularly insightful perspectives on how early-stage science is evaluated by pharma and investors, as well as what it takes to translate research into scalable, investable platforms.
We look forward to continuing these conversations and exploring opportunities for collaboration in Japan and across APAC.